Label free inhibitor screening of hepatitis C virus (HCV) NS5B viral protein using RNA oligonucleotide

Sensors

Volumn 11, Issue 7, 2011, Pages 6685-6696

  Roh, Changhyun ^a   Kim, Sang Eun ^b   Jo, Sung Kee ^a  

^a Korea Atomic Energy Research Institute   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Inhibitor; RNA oligonucleotide; Streptavidin biotin conjugation; Viral protein

Indexed keywords

ANTIVIRUS AGENT; APTAMER; BIOTIN; CATECHIN; DRUG DERIVATIVE; EPIGALLOCATECHIN GALLATE; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; STREPTAVIDIN; VIRUS PROTEIN;

ARTICLE; CHEMISTRY; COMPUTER SYSTEM; DRUG ANTAGONISM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; ISOLATION AND PURIFICATION;

ANTIVIRAL AGENTS; APTAMERS, NUCLEOTIDE; BIOTIN; CATECHIN; COMPUTER SYSTEMS; HEPACIVIRUS; HEPATITIS C; HUMANS; STREPTAVIDIN; VIRAL NONSTRUCTURAL PROTEINS;

EID: 79960754160     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s110706685     Document Type: Article

References (27)

1. Castello, G.; Scala, S.; Palmieri, G.; Curley, S.A.; Izzo, F. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer. Clin. Immunol. 2010, 134, 237-250.
2. Maheshwari, A.; Thuluvath, P.J. Management of acute hepatitis C. Clin. Liver Disease 2010, 14, 169-176.
3. Pawlotsky, J.M. Hepatitis C virus population dynamics during infection. Curr. Top. Microbiol. Immunol. 2006, 299, 261-284.
4. Reed, K.E.; Rice, C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 2000, 242, 55-84.
5. De Francesco, R.; Tomei, L.; Altamura, S.; Summa, V.; Migliaccio, G. Approaching a new era for hepatitis C virus therapy: Inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antiviral Res. 2003, 58, 11-16.
6. Bressanelli, S.; Tomei, L.; Roussel, A.; Incitti, I.; Vitale, R.L.; Mathieu, M.; de Francesio, R.; Rey, F.A. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Proc. Nat. Acad. Sci. USA 1999, 96, 13034-13039.
7. Yamashita, T.; Kaneko, S.; Shirota, Y.; Qin, W.; Nomura, T.; Kobayashi, K.; Murakami, S. RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J. Biol. Chem. 1998, 273, 15479-15486.
8. Cullen, B.R. Immunology. Outwitted by viral RNAs. Science 2007, 317, 329-330.
9. Gaudy, C.; Thevenas, C.; Tichet, J.; Mariotte, N.; Goudeau, A.; dubois, F. Usefulness of the hepatitis C virus core antigen assay for screening of a population undergoing routine medical checkup. J. Clin. Microbiol. 2005, 43, 1722-1726.
10. Tang, Y.; Li, H.; Roberto, A.; Warner, D.; Yen-Lieberman, B. Detection of hepatitis C virus by a user-developed reverse transcriptase-PCR and use of amplification products for subsequent genotyping. J. Clin. Virol. 2004, 2, 148-152.
11. Jayasena, S.D. Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin. Chem. 1999, 45, 1628-1650.
12. Breaker, R.R.: DNA enzymes. Nat. Biotech. 1997, 15, 427-431.
13. Riccardi, C.S.; Kranz, C.; Kowalik, J.; Yamanaka, H.; Mizaikoff, B.; Josowicz, M. Label-free DNA detection of hepatitis C virus based on modified conducting polypyrrole films at microelectrodes and AFM-tip integrated electrodes. Anal. Chem. 2008, 80, 237-245.
14. Zheng, D.; Seferos, D.S.; Giljohann, D.A.; Patel, P.C.; Mirkin, C.A. Aptamer Nano-flares for Molecular Detection in Living Cells. Nano Lett. 2009, 9, 3258-3261.
15. Tuerk, C.; Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249, 505-510.
16. Burgstaller, P.; Girod, A.; Blind, M. Aptamers as tools for target prioritization and lead identification. Drug Disco. Today 2002, 7, 1221-1228.
17. Gold, L.; Allen, P.; Binkley, J.; Brown, D.; Schneider, D.; Eddy, S.R. RNA: The shape of things to come, in The RNA World; Gestelend, R.F., Atkins, J.F., Eds.; Harbor Laboratory Press: Cold Spring Harbor, NY, USA, 1993; pp. 497-510.
18. Abdiche, Y.; Malashock, D.; Pinkerton, A.; Pons, J. Determining kinetics and affinities of protein interactions using a parallel real-time label-free Biosensor. Anal. Biochem. 2008, 377, 209-217.
19. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680-685.
20. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
21. Lotze, M.T. Label-Free, Real-Time Detection System for Molecular Interaction Analysis. U.S. Patent 20,090,147,264, 6 November 2009.
22. Farkas, A.M.; Kilgore, T.M.; Lotze, M.T. Detecting DNA: Getting and begetting cancer. Curr. Opin. Invest. Drugs 2007, 8, 981-986.
23. Golemba, M.D.; Lello, F.A.D.; Bessone, F.; Fay, F.; Benetti, S.; Jones, L.R.; Campos, R.H. High prevalence of hepatitis C virus genotype 1b infection in a small town of argentina, Phylogenetic and Bayesian Coalescent analysis. PloS One 2010, 5, e8751.
24. Roh, C.; Lee, H.Y.; Kim, S.E.; Jo, S.K. A highly sensitive and selective viral protein detection method based on RNA oligonucleotide nanoparticle. Int. J. Nanomed. 2010, 5, 323-329.
25. Ciesek, S.; Steinmann, E.; Wedemeyer, H.; Manns, M.P.; Neyts, J.; Tautz N., Madan, V.; Bartenschlager, R.; Hahn, T.; Pietschmann, T. Cyclosporine A inhibits hepatitis C virus nonstrucutural protein 2 through cyclophilin A. Hepatology 2009, 5, 1638-1645.
26. Ivanov, A.V.; Kozlov, M.V.; Kuzyakin, A.O.; Kostyuk, D.A.; Tunitskaya, V.L.; Kochetkov, S.N. New non_nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase. Biochemitry (Moscow) 2004, 69, 782-788.
27. Kozlov, M.V.; Polyakov, K.M.; Ivanov, A.V.; Filippova, S.E.; Kuzyakin, A.O.; Tunitskaya, V.L.; Kochetkov, S.N. Hepatitis C virus RNA-dependent RNA polymerase: Study on the inhibition mechanism by pyrogallol derivatives. Biochemitry (Moscow) 2006, 71, 1021-1026.